Literature DB >> 3935462

Nitroglycerin disposition in human blood.

P A Cossum, M S Roberts.   

Abstract

The disposition in vitro of nitroglycerin (GTN) and its metabolites in erythrocyte suspensions, plasma and blood has been studied using labelled (3H) and unlabelled GTN and GTN metabolites separated by HPLC. GTN was rapidly metabolised (t1/2 3 min) to dinitro-metabolites and subsequently to the mononitronitrates in erythrocyte suspensions containing a therapeutic concentration of GTN (0.8-10 ng/ml). The metabolism of GTN and its dinitro-metabolites was concentration dependent. GTN and its dinitro-metabolites were plasma protein bound (11-60%). They had an apparent erythrocyte-plasma partition coefficient in the range 0.6 to 0.9. The metabolism of GTN by erythrocytes was partially inhibited by the presence of the dinitro-metabolites of GTN. The metabolism of GTN in blood samples collected from patients could be stopped by adding the collected blood to chilled tubes containing the enzyme inhibitor iodoacetamide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935462     DOI: 10.1007/bf00547417

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Micro determination of glyceryl trinitrate in biological fluids; effect of deuteration of glyceryl trinitrate on its pharmacokinetic properties.

Authors:  I W Taylor; C Ioannides; J C Turner; R U Koenigsberger; D V Parke
Journal:  J Pharm Pharmacol       Date:  1981-04       Impact factor: 3.765

3.  Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure.

Authors:  J A Franciosa; R C Blank; J N Cohn
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

4.  Metabolism of and vascular responses to glyceryl trinitrate in the eviscerated rat.

Authors:  S Lang; E M Johnson; P Needleman
Journal:  Biochem Pharmacol       Date:  1972-02-01       Impact factor: 5.858

5.  Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects.

Authors:  E Rey; H D El-Assaf; M O Richard; S Weber; A Bourdon; G Picard; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Biotransformation of glyceryl trinitrate to glyceryl dinitrate by human hemoglobin.

Authors:  B M Bennett; K Nakatsu; J F Brien; G S Marks
Journal:  Can J Physiol Pharmacol       Date:  1984-06       Impact factor: 2.273

7.  Intravenous nitroglycerin in acute myocardial infarction.

Authors:  J T Flaherty; P R Reid; D T Kelly; D R Taylor; M L Weisfeldt; B Pitt
Journal:  Circulation       Date:  1975-01       Impact factor: 29.690

8.  Improved GLC determination of plasma nitroglycerin concentrations.

Authors:  P S Yap; E F McNiff; H L Fung
Journal:  J Pharm Sci       Date:  1978-04       Impact factor: 3.534

9.  Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.

Authors:  E F McNiff; A Yacobi; F M Young-Chang; L H Golden; A Goldfarb; H L Fung
Journal:  J Pharm Sci       Date:  1981-09       Impact factor: 3.534

10.  Interaction of nitroglycerin with human blood components.

Authors:  T D Sokoloski; C C Wu; L S Wu; A M Burkman
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

View more
  10 in total

1.  Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.

Authors:  E Nakashima; P K Noonan; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

2.  Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.

Authors:  H Laufen; M Leitold
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

6.  Variable glyceryl dinitrate formation following infusions of glyceryl trinitrate at different vascular sites in the rat.

Authors:  E Nakashima; D T Lau; L Z Benet
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

7.  Nitroglycerin dinitrate metabolites do not affect the pharmacokinetics and pharmacodynamics of nitroglycerin in the dog: a preliminary report.

Authors:  F W Lee; J Hu; C H Metzler; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1993-04

8.  A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats.

Authors:  E L Bachert; Z W Li; L Zhao; S J Chung; H L Fung
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

9.  Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.

Authors:  F W Lee; T Salmonson; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1993-10

Review 10.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.